Busca avançada
Ano de início
Entree
(Referência obtida automaticamente do Web of Science, por meio da informação sobre o financiamento pela FAPESP e o número do processo correspondente, incluída na publicação pelos autores.)

New linear antiplasmodial peptides related to angiotensin II

Texto completo
Autor(es):
Silva, Adriana Farias [1] ; Torossian Torres, Marcelo Der [1] ; Silva, Leandro de Souza [2] ; Alves, Flavio Lopes [3] ; de Sa Pinheiro, Ana Acacia [2] ; Miranda, Antonio [3] ; Capurro, Margareth Lara [4] ; Oliveira, Jr., Vani Xavier [1]
Número total de Autores: 8
Afiliação do(s) autor(es):
[1] Univ Fed ABC, Ctr Ciencias Nat & Humanas, BR-09210170 Santo Andre, SP - Brazil
[2] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, BR-21941 Rio De Janeiro, RJ - Brazil
[3] Univ Fed Sao Paulo, Dept Biofis, Sao Paulo, SP - Brazil
[4] Univ Sao Paulo, Inst Ciencias Biomed 2, Dept Parasitol, Sao Paulo, SP - Brazil
Número total de Afiliações: 4
Tipo de documento: Artigo Científico
Fonte: Malaria Journal; v. 14, NOV 4 2015.
Citações Web of Science: 3
Resumo

Background: Antiplasmodial activities of angiotensin II and its analogues have been extensively investigated in Plasmodium gallinaceum and Plasmodium falciparum parasite species. Due to its vasoconstrictor property angiotensin II cannot be used as an anti-malarial drug. Methods: This work presents the solid-phase syntheses and liquid chromatography and mass spectrometry characterization of ten linear peptides related to angiotensin II against mature P. gallinaceum sporozoites and erythrocyte invasion by P. falciparum. Conformational analyses were performed by circular dichroism. IC50 assays were performed to identify the ideal concentration used on the biological tests and haemolytical erythrocytic assays were made to verify the viability of the biological experiments. The contractile responses of the analogues were made to evaluate if they are promising candidates to be applied as antiplasmodial drugs. Results: The results indicate two short-peptides constituted by hydrophobic residues (5 and 6) with antiplasmodial activity in these models, 89 and 94 % of biological activity against P. gallinaceum sporozoite, respectively, and around 50 % of activity against P. falciparum. Circular dichroism spectra suggested that all the peptides adopted beta-turn conformation in different solutions, except peptide 3. Besides the biological assays IC50, the haemolysis assays and contractile response activities were applied for peptides 5 and 6, which did not present expressive results. Conclusions: The hydrophobic portion and the arginine, tyrosine, proline, and phenylalanine, when present on peptide primary sequence, tend to increase the antiplasmodial activity. This class of peptides can be explored, as antimalarial drugs, after in vivo model tests. (AU)

Processo FAPESP: 11/11348-2 - Peptídeos Antimaláricos Derivados da Angiotensina II
Beneficiário:Adriana Farias da Silva
Modalidade de apoio: Bolsas no Brasil - Doutorado
Processo FAPESP: 11/10823-9 - Compostos antimaláricos derivados da angiotensina II
Beneficiário:Vani Xavier de Oliveira Junior
Modalidade de apoio: Auxílio à Pesquisa - Regular
Processo FAPESP: 14/12938-6 - Peptídeos biologicamente ativos em micro-organismos patogênicos
Beneficiário:Vani Xavier de Oliveira Junior
Modalidade de apoio: Auxílio à Pesquisa - Regular